We are a clinical-stage biotechnology company dedicated to the development of novel therapeutics that transform the treatment of challenging brain-related conditions.
As a Public Benefit Corporation (PBC), we are developing novel biopharmaceutical products in a responsible manner with the intent to generate social good while empowering indigenous communities where these healing traditions originated. We collaborate with like-minded non-profit organizations to foster growth, advance knowledge and support educational opportunities.
We are developing GMP-grade ibogaine as a novel treatment for brain-related conditions that lack effective treatments. Learn more about this groundbreaking effort with a molecule of historic and scientific importance.
We uphold the highest standards in clinical development and safety, while giving back to the communities and ecosystems that inspire our therapeutic work.
